Literature DB >> 12125224

Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.

L Schreier1, G Berg, V Zago, A I Gonzalez, R Wikinski.   

Abstract

BACKGROUND AND AIM: An initial step in the catabolism of triglyceride-rich lipoprotein involves the hydrolysis of the triglyceride moiety by lipoprotein lipase (LPL). As differences in the lipolytic behaviour of very low-density lipoprotein (VLDL) particles have been observed, it is possible that different VLDL particles have a different affinity to the enzyme, which means that their fate may partially depend on the LPL-mediated hydrolysis of their triglyceride content. Our aim was to determine whether variation in VLDL chemical composition affects their properties as a substrate for LPL. METHODS AND
RESULTS: Isolated VLDL was incubated in vitro with bovine LPL to determine substrate affinity. Under optimal assay conditions, free fatty acids were measured and the kinetic indicators for in vitro triglyceride hydrolysis (Km and Vmax) were calculated. VLDL cholesterol (VLDL-C), VLDL-apoB and the cholesterol/triglyceride ratio were assessed and the triglyceride/protein and triglyceride/apoB ratios were calculated as lipoprotein size estimators. VLDL-C, VLDL-apoB and the VLDL-C/triglyceride ratio positively correlated with Km: r = 0.52, p < 0.01; r = 0.52, p < 0.03; r = 0.69, p < 0.001 respectively. No correlation was found between the VLDL-triglyceride/protein or the VLDL-triglyceride/apoB ratios and Km (r = -0.20, and -0.06 respectively, p = not significant). Of the subjects' anthropometric characteristics, only the waist/hip ratio significantly correlated with Km: r = 0.63, p < 0.01.
CONCLUSIONS: In the present study, we investigated the substrate function of VLDL particles in vitro. Enzyme affinity seems to be associated with cholesterol-triglyceride content or the number of VLDL particles rather than particle size. It may be expected that VLDL with a low cholesterol/triglyceride ratio will be efficiently lypolised by LPL, thus leading to the formation of a smaller particle with atherogenic potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125224

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  3 in total

1.  Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Ben van Ommen; Kees van Bochove; Patrick C N Rensen; Louis M Havekes; Niek C A van de Pas; Huub C J Hoefsloot; Jan van der Greef; Andreas P Freidig
Journal:  J Lipid Res       Date:  2009-06-10       Impact factor: 5.922

2.  Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profiles.

Authors:  D L Ellsworth; N S Costantino; H L Blackburn; R J M Engler; M Kashani; M N Vernalis
Journal:  Obes Sci Pract       Date:  2016-07-25

3.  Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.

Authors:  John S Millar; Michael E Lassman; Tiffany Thomas; Rajasekhar Ramakrishnan; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Soumia Aoujil; Taylor Standiford; David E Gutstein; Henry N Ginsberg; Daniel J Rader; Gissette Reyes-Soffer
Journal:  J Lipid Res       Date:  2017-03-17       Impact factor: 5.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.